publication venue for Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card. 8:e00555. 2020 Nerve growth factor inhibitor with novel‐binding domain demonstrates nanomolar efficacy in both cell‐based and cell‐free assay systems. 5. 2017
has subject area 0304 Medicinal and Biomolecular Chemistry (FoR) 1115 Pharmacology and Pharmaceutical Sciences (FoR)
